Back
Vanguard S&P Mid-Cap 400 Index Fund ETF Vs. Olema Pharmaceuticals, Inc. Industry Stock Comparison
Buy
55
IVOO
Vanguard S&P Mid-Cap 400 Index Fund ETF
Last Price:
$113.61
Seasonality Move:
6%
Buy
66
OLMA
Olema Pharmaceuticals, Inc.
Last Price:
$33.03
Seasonality Move:
-6.94%
Buy
55
Vanguard S&P Mid-Cap 400 Index Fund ETF (IVOO)
is a Buy
Is Vanguard S&P Mid-Cap 400 Index Fund ETF a Buy, Sell or Hold?
-
The current Vanguard S&P Mid-Cap 400 Index Fund ETF [IVOO] share price is $113.65. The Score for IVOO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
IVOO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Olema Pharmaceuticals, Inc. (OLMA)
is a Buy
Is Olema Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Olema Pharmaceuticals, Inc. [OLMA] share price is $33.05. The Score for OLMA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
OLMA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IVOO Stock Price Chart
What is Vanguard S&P Mid-Cap 400 Index Fund ETF's stock price today?
-
The Vanguard S&P Mid-Cap 400 Index Fund ETF share price today is $113.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IVOO is experiencing selling pressure, which indicates risk of future bearish movement.
OLMA Stock Price Chart
What is Olema Pharmaceuticals, Inc.'s stock price today?
-
The Olema Pharmaceuticals, Inc. share price today is $33.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OLMA is experiencing buying pressure, which is a positive indicator for future bullish movement.
IVOO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.14 | Buy |
| Relative Strength Index (14 RSI): | 59.84 | Buy |
| Chaikin Money Flow: | -31478 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (108.1 - 112.96) | Buy |
| Bollinger Bands (100): | (107.8 - 111.82) | Buy |
OLMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.91 | Buy |
| Relative Strength Index (14 RSI): | 83.22 | Buy |
| Chaikin Money Flow: | 2330353 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.75 - 30.25) | Buy |
| Bollinger Bands (100): | (3.36 - 18.7) | Buy |
IVOO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 112.97 | Buy |
| 20-day SMA: | 110.64 | Buy |
| 50-day SMA: | 110.3 | Buy |
| 200-day SMA: | 105.35 | Buy |
| 8-day EMA: | 113.03 | Buy |
| 20-day EMA: | 111.65 | Buy |
| 50-day EMA: | 110.57 | Buy |
| 200-day EMA: | 107.45 | Buy |
OLMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29 | Buy |
| 20-day SMA: | 24.82 | Buy |
| 50-day SMA: | 15.4 | Buy |
| 200-day SMA: | 7.73 | Buy |
| 8-day EMA: | 29.46 | Buy |
| 20-day EMA: | 24.88 | Buy |
| 50-day EMA: | 18.05 | Buy |
| 200-day EMA: | 10.4 | Buy |
Vanguard S&P Mid-Cap 400 Index Fund ETF Earnings Growth & IVOO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Olema Pharmaceuticals, Inc. Earnings Growth & OLMA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.59 per share, and a decrease next year of $0.42 per share.
Vanguard S&P Mid-Cap 400 Index Fund ETF Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Olema Pharmaceuticals, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||